Press release -

Sean O'Reilly East Northport attending BIO-Europe conference in Germany

The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emergingBIO-Europe plays host to executives from:

  • Established and emerging biotech companies
  • Pharmaceutical companies
  • Companies developing companion diagnostics
  • Institutional financial firms
  • Private investors including venture capital and private equity
  • Industry related service companies

companies. Produced with the support of BIO, it is regarded as a “must attend” event for the biotech industry.

EBD Group invites biotech, midsize pharmaceutical, and next generation companies to submit an application for a company presentation at BIO-Europe® 2011.

High level faculty on panels and workshops, in which industry experts provide updated analyses and share their experience with the audience.

A lively exhibition in the heart of the conference area showcasing services and technologies.

BIO-Europe 2010 Highlights

  • 14,661 scheduled one-to-one meetings (+17% over 2009)
  • 3,243 licensing opportunities were posted (+22% over 2009)
  • 2,906 attendees (+16% over 2009)
  • 1,688 companies (+21% over 2009)
  • 170 company presentations
  • 87 international exhibitors
  • 48 countries
  • 21 workshops and panel sessions

For more info:


  • Science, technology


  • sean oreilly east northport
  • bio tech
  • sean oreilly huntington


  • New York